BPL’s Human Albumin is our first ever product approved in the Chinese market
A commitment for life
Therapy Areas & Products
BPL manufactures a wide range of products from blood plasma. These products fall broadly into three main therapy areas: immunology, critical care and coagulation disorders. The safety and quality of these plasma products is supported by BPL’s Quality Management Framework.
BPL’s R&D mission is to provide scientific and technical expertise to execute new product pipeline initiatives on time and to discover new products for commercialisation in order to provide a future for the business.
BPL’s commitment to quality is allied to its longstanding investment in its underlying scientific knowledge-base and R&D capability, led by the team of specialists in plasma therapies based in Elstree.More about R&D
BPL is focused on embracing its environmental, social and governance responsibilities.
BPL is committed to ensuring high standards of governance are maintained across the business, and is increasing its efforts to minimise its environmental impact.More about responsibility
2023 ISTH Congress, Kedrion confirms its commitment to rare and ultra-rare diseases
Kedrion’s global portfolio expands to China to supply human Albumin
BPL joins Rare Disease Day
Raising awareness and generating change for the people living with a rare disease
We offer excellent career opportunities across our departments.
Find out from our employees on what a career at BPL can offer you.
What we offer
To us, job satisfaction is the biggest benefit to working at BPL.
Whether we have an open vacancy right now or not, we would love to hear from you.